Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Current Leases (2023 - 2024)

Immunome's Current Leases history spans 2 years, with the latest figure at $63000.0 for Q4 2024.

  • For Q4 2024, Current Leases fell 79.68% year-over-year to $63000.0; the TTM value through Dec 2024 reached $63000.0, down 79.68%, while the annual FY2024 figure was $63000.0, 79.68% down from the prior year.
  • Current Leases reached $63000.0 in Q4 2024 per IMNM's latest filing, down from $257000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $310000.0 in Q4 2023 to a low of $63000.0 in Q4 2024.